Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,109,835 papers from all fields of science
Search
Sign In
Create Free Account
Spiradenocarcinoma
Known as:
Malignant Eccrine Spiradenoma
, Malignant Spiradenoma
A very rare, aggressive carcinoma of the sweat glands arising from malignant transformation of a long standing spiradenoma. It usually grows in the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Epithelial Cells
Epithelium
Exocrine system
Integumentary system
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Malignant spiradenoma/cylindroma of the vulva.
Eman Emam
,
A. Sawan
,
Soha R Al-Tamimi
,
Rihab Molah
Saudi Medical Journal
2012
Corpus ID: 24674184
Malignant spiradenoma/cylindroma of the vulva is an extremely rare adnexal tumor. We report the clinicopathological features of a…
Expand
2009
2009
Spiradenocylindrocarcinoma. Report of a Case With a Low-Grade Component of Spiradenocarcinoma and an Immunohistochemical Study
G. Apostolou
,
N. Apostolou
,
P. Chatzipantelis
,
Maria Biteli
American journal of dermatopathology
2009
Corpus ID: 26348146
Spiradenocylindrocarcinoma is a very rare malignant cutaneous neoplasm of the folliculosebaceous-apocrine unit. We report a case…
Expand
2008
2008
A case of malignant eccrine spiradenoma metastatic to intramammary lymph node
Yuko Tanaka
,
E. Bhunchet
,
Toshikatsu Shibata
Breast Cancer
2008
Corpus ID: 28026871
Eccrine spiradenoma (ES) is a fairly common, benign, cutaneous tumor originating from the sweat glands. In contrast, the…
Expand
Review
2006
Review
2006
Malignant eccrine spiradenoma of the vulva: a case report and review of the literature.
D. Chase
,
T. Basu
,
B. Saffari
,
S. Ries
,
M. Berman
International Journal of Gynecological Cancer
2006
Corpus ID: 36753377
Malignant eccrine spiradenoma is a rare skin tumor of sweat gland origin. We present the first reported case of this tumor in the…
Expand
Review
2003
Review
2003
Low-grade malignant eccrine spiradenoma with systemic metastases.
N. Leonard
,
David Smith
,
P. McNamara
American journal of dermatopathology
2003
Corpus ID: 29471616
Malignant eccrine spiradenoma (MES) is a very rare tumor. Tumors can be low grade or high grade. There are nine cases in the…
Expand
1999
1999
A Case of Malignant Eccrine Spiradenoma.
Eiko Wakeyama
,
T. Shukuwa
,
I. Katayama
,
F. Toriyama
1999
Corpus ID: 72017913
58歳男性。30年来の左上肢屈側に線状配列したeccrine spiradenomaのうちの1個が, 約半年間で母指頭大に急激に増大した。病理組織学的に, 真皮浅層に好塩基性の細胞とやや明るい細胞質を有する2種の細胞よりなるeccrine…
Expand
Review
1996
Review
1996
Malignant eccrine spiradenoma with smooth muscle cell differentiation: Histological and immunohistochemical study
T. Itoh
,
N. Yamamoto
,
M. Tokunaga
Pathology international (Print)
1996
Corpus ID: 22079652
Malignant transformation in a benign eccrlne eplradenoma Is rare. Since It was flrst reported In 1972, 31 cases have been…
Expand
1993
1993
An uncommon breast tumour: the malignant eccrine spiradenoma. A case report.
B. Thomas
,
V. Duwel
,
L. Proot
,
J. Vanvuchelen
Acta Chirurgica Belgica
1993
Corpus ID: 37695009
Eccrine spiradenoma is a benign tumour originating from cutaneous sweat glands. It rarely develops into a malignant tumour. A…
Expand
Review
1990
Review
1990
Malignant eccrine spiradenoma of the hand
A. Zamboni
,
W. Zamboni
,
D. Ross
Journal of Surgical Oncology
1990
Corpus ID: 35190820
A malignant eccrine spiradenoma (MES) of the hand is described in a patient who developed bilateral pulmonary metastasis more…
Expand
1990
1990
Fine needle aspiration cytology of malignant spiradenoma arising in congenital eccrine spiradenoma.
Varsa Ew
,
Jordan Sw
Acta Cytologica
1990
Corpus ID: 76874822
The fine needle aspiration (FNA) cytology of malignant eccrine spiradenoma arising in a large benign congenital eccrine…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE